Targeting ECM/Integrin Interaction with Liposome-Encapsulated Small Interfering RNAs Inhibits the Growth of Human Prostate Cancer in Bone in a Xenograft Imaging Model. Molecular Therapy

ASIAIR > College of Medical and Health Science > Department of Biotechnology > Journal Article > Item 310904400/4607

Please use this identifier to cite or link to this item: http://asiair.asia.edu.tw/ir/handle/310904400/4607

Title:	Targeting ECM/Integrin Interaction with Liposome-Encapsulated Small Interfering RNAs Inhibits the Growth of Human Prostate Cancer in Bone in a Xenograft Imaging Model. Molecular Therapy
Authors:	Kristen Bisanz;Magnus Edlund;Bill Spohn;Mien-Chie Hung;Leland W. K. Chung
Keywords:	small interfering RNA;prostate cancer bone metastasis;integrins, extracellular matrix;noninvasive imaging;bioluminescence
Date:	2005-10
Issue Date:	2009-11-27 05:57:02 (UTC+0)
Publisher:	Asia University
Abstract:	The intricate intracellular communication between stromal and epithelial cells, which involves cell?cell-, cell?insoluble extracellular matrix- (ECM), and cell?soluble factor-mediated signaling processes, is an attractive target for therapeutic intervention in hormone-refractory and bone-metastatic prostate cancer. In the present study we demonstrated that androgen-independent PC3 prostate cancer cells adhered to and migrated on vitronectin (VN), a major noncollagenous ECM in mature bone, through the expression of v-containing integrin receptors v1 and v5 on the cell surface, as determined by antibody function blocking assay and flow cytometry analysis. Small interfering RNAs (siRNAs) targeting human integrin v markedly reduced their respective mRNA and protein expression in cells, resulting in nearly complete reduction in VN-mediated cancer progression in vitro. In vivo quantitative bioluminescence analysis of human prostate cancer bone xenografts demonstrated for the first time that intratumoral administration of liposome-encapsulated human v-siRNAs significantly inhibits the growth of luciferase-tagged PC3 tumors in skeleton, which was associated with decreased integrin v expression and increased apoptosis in tumor cells. This integrin-based gene therapy is particularly suitable for the treatment of prostate cancer bone metastasis.
Relation:	MOLECULAR THERAPY 4(12):634-643
Appears in Collections:	[Department of Biotechnology] Journal Article

Files in This Item:

File	Description	Size	Format
		0Kb	Unknown	677	View/Open
310904400-4607.doc		33Kb	Microsoft Word	462	View/Open

Loading...